FDA warns Curaleaf about inflated claims in CBD product marketing
5 years ago
21
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
1:23
WFTX
1 year agoMarco Patriots headed home after helping people impacted by Idalia
813 -
0:42
KMGH
2 years agoBBB warns about travel scams
55 -
0:43
KMGH
3 years agoBBB warns about counterfeit items
52 -
0:53
KMGH
2 years agoBBB warns about weight loss supplements
15 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
2 years agoFBI warns about popular Facebook scam
83 -
1:31:05
Kim Iversen
3 days agoShe Predicted Putin Would Invade Ukraine – What Happens Next Is Terrifying | Rebekah Koffler
48.6K67 -
1:04:51
Bright Insight
3 hours agoWhat I Didn't Say to Joe Rogan on his Podcast
43.8K31 -
LIVE
Talk Nerdy 2 Us
7 hours agoPhishing Scams, Satellite Phones & Piracy Networks: Cybercrime's Next Leve
486 watching